Practice
Featured experience
Novo Nordisk proposed $9.1 billion acquisition of Metsera
We are advising Novo Nordisk on the transaction
HNI $2.2 billion acquisition of Steelcase
We are advising HNI on the transaction
Amer Sports $1.3 billion secondary offering
We advised Amer Sports on its SEC-registered secondary offering of ordinary shares
Cintas $5.3 billion proposal to acquire UniFirst
We are advising Cintas on the proposed acquisition
Atour Lifestyle Holdings $194.4 million secondary offering
We advised Atour on a secondary offering of ADSs
ProKidney $140 million follow-on offerings
We advised ProKidney on the offering
Aptiv €750 million senior notes offering
We advised Aptiv on the investment-grade debt offering
Royalty Pharma $1.5 billion senior notes offering
We advised Royalty Pharma on its investment-grade notes offering
Emerson $3.5 billion sale of remaining interests in Copeland to Blackstone
We are advising Emerson on the sale
Verisk $600 million senior notes offering and concurrent tender offer
We advised Verisk in connection with the transactions
Equinix $750 million bond offering
We advised Equinix on the investment-grade debt offering
Mirion Technologies warrant redemption
We advised Mirion Technologies on the redemption of its public warrants
Baldwin Group $600 million senior secured notes offering and $1.44 billion credit facilities
We advised the Baldwin Group on the financing
Nordson $800 million acquisition of Atrion
We are advising Nordson on the acquisition